Skandinaviska Enskilda Banken Ab (Publ) Abb Vie Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $24.3 Billion
  • Q3 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Abb Vie Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 947,375 shares of ABBV stock, worth $222 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
947,375
Previous 884,419 7.12%
Holding current value
$222 Million
Previous $164 Million 33.62%
% of portfolio
0.9%
Previous 0.73%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$184.85 - $231.54 $11.6 Million - $14.6 Million
62,956 Added 7.12%
947,375 $219 Million
Q2 2025

Aug 13, 2025
SELL
$170.16 - $206.27 $1.72 Million - $2.08 Million
-10,092 Reduced 1.13%
884,419 $164 Million
Q1 2025

May 07, 2025
SELL
$169.2 - $216.66 $17.2 Million - $22 Million
-101,646 Reduced 10.2%
894,511 $187 Million
Q4 2024

Feb 10, 2025
SELL
$164.99 - $203.87 $58.1 Million - $71.8 Million
-352,147 Reduced 26.12%
996,157 $177 Million
Q3 2024

Nov 07, 2024
SELL
$163.84 - $199.33 $28.4 Million - $34.6 Million
-173,641 Reduced 11.41%
1,348,304 $266 Million
Q2 2024

Aug 13, 2024
SELL
$154.79 - $180.76 $799,335 - $933,444
-5,164 Reduced 0.34%
1,521,945 $261 Million
Q1 2024

May 13, 2024
BUY
$159.82 - $182.1 $43.2 Million - $49.2 Million
270,034 Added 21.48%
1,527,109 $278 Million
Q4 2023

Feb 14, 2024
BUY
$137.6 - $154.97 $6.49 Million - $7.31 Million
47,201 Added 3.9%
1,257,075 $195 Million
Q3 2023

Nov 09, 2023
BUY
$133.59 - $154.65 $48.6 Million - $56.2 Million
363,528 Added 42.95%
1,209,874 $180 Million
Q2 2023

Aug 07, 2023
BUY
$132.51 - $164.9 $28.3 Million - $35.2 Million
213,494 Added 33.74%
846,346 $114 Million
Q1 2023

May 11, 2023
SELL
$144.61 - $166.54 $25.2 Million - $29.1 Million
-174,550 Reduced 21.62%
632,852 $101 Million
Q4 2022

Feb 08, 2023
SELL
$138.31 - $165.87 $34.6 Million - $41.5 Million
-250,358 Reduced 23.67%
807,402 $130 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $16.4 Million - $18.8 Million
-122,098 Reduced 10.35%
1,057,760 $142 Million
Q2 2022

Aug 10, 2022
SELL
$137.62 - $174.96 $17.8 Million - $22.6 Million
-129,310 Reduced 9.88%
1,179,858 $181 Million
Q1 2022

May 11, 2022
SELL
$131.98 - $163.75 $16.2 Million - $20.1 Million
-122,586 Reduced 8.56%
1,309,168 $213 Million
Q4 2021

Feb 10, 2022
BUY
$107.43 - $135.93 $55 Million - $69.6 Million
512,174 Added 55.7%
1,431,754 $195 Million
Q3 2021

Nov 10, 2021
BUY
$106.4 - $120.78 $6.81 Million - $7.73 Million
64,034 Added 7.48%
919,580 $99.3 Million
Q2 2021

Aug 10, 2021
BUY
$105.21 - $117.21 $3.94 Million - $4.39 Million
37,490 Added 4.58%
855,546 $96.4 Million
Q1 2021

May 14, 2021
BUY
$102.3 - $112.62 $9.99 Million - $11 Million
97,620 Added 13.55%
818,056 $88.7 Million
Q4 2020

Feb 11, 2021
BUY
$80.49 - $108.67 $296,847 - $400,774
3,688 Added 0.51%
720,436 $77.2 Million
Q3 2020

Nov 12, 2020
BUY
$85.91 - $100.83 $4.88 Million - $5.72 Million
56,760 Added 8.6%
716,748 $62.8 Million
Q2 2020

Aug 13, 2020
BUY
$73.37 - $98.18 $5.37 Million - $7.19 Million
73,217 Added 12.48%
659,988 $64.8 Million
Q1 2020

May 13, 2020
SELL
$64.5 - $97.79 $1.45 Million - $2.19 Million
-22,414 Reduced 3.68%
586,771 $44.7 Million
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $57.6 Million - $72.1 Million
-799,090 Reduced 56.74%
609,185 $53.9 Million
Q3 2019

Nov 08, 2019
BUY
$62.98 - $75.72 $3.81 Million - $4.58 Million
60,422 Added 4.48%
1,408,275 $107 Million
Q2 2019

Aug 09, 2019
BUY
$65.7 - $83.98 $21.9 Million - $28 Million
333,183 Added 32.84%
1,347,853 $98 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $3.87 Million - $4.56 Million
-50,199 Reduced 4.71%
1,014,670 $81.8 Million
Q4 2018

Feb 12, 2019
BUY
$77.85 - $96.01 $5.42 Million - $6.68 Million
69,605 Added 6.99%
1,064,869 $98.2 Million
Q3 2018

Nov 05, 2018
SELL
$88.91 - $98.84 $1.07 Million - $1.19 Million
-11,990 Reduced 1.19%
995,264 $94.1 Million
Q2 2018

Aug 14, 2018
BUY
$89.78 - $106.23 $7.83 Million - $9.26 Million
87,189 Added 9.48%
1,007,254 $93.3 Million
Q1 2018

Apr 30, 2018
SELL
$92.01 - $123.21 $10.1 Million - $13.5 Million
-109,787 Reduced 10.66%
920,065 $87.1 Million
Q4 2017

Feb 12, 2018
SELL
$89.56 - $98.21 $8.92 Million - $9.78 Million
-99,610 Reduced 8.82%
1,029,852 $99.6 Million
Q3 2017

Nov 13, 2017
SELL
$69.85 - $89.22 $6.27 Million - $8 Million
-89,700 Reduced 7.36%
1,129,462 $100 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,219,162
1,219,162 $0

Others Institutions Holding ABBV

# of Institutions
4,489
Shares Held
1.28B
Call Options Held
17.1M
Put Options Held
15.4M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email